NRSNW NEUROSENSE THERAPEUTICS LTD C/W
$0.05▲ +0.00%
Unknown
Other
Volume 94
Avg Volume (10D) –
Key Metrics & Fundamentals
Market Cap
–
P/E Ratio
–
Div Yield
–%
52W Range
0.05 - 0.07
% vs 50 MA
-69.60%
% vs 200 MA
–%
RSI-14
38.5
MACD Histogram
+0.0000
Beta (1Y vs SPY)
3.18
Gross Rev
$0
Gross Profit
$0
EBITDA
-$1.77M
COGS
–
Operating Exp
$1.77M
Operating Income
-$1.77M
EBIT
-$1.77M
Pretax Income
-$1.80M
Net Income
-$1.80M
Price & Volume History
Loading chart…
Recent News
NeuroSense to Present at H.C. Wainwright 28th Annual Global Investment Conference
PR Newswire · Sep 10, 2026 1:00 PM
NeuroSense Unveils Accelerated, Capital-Efficient Strategy to Advance PrimeC Toward Potential Approval in ALS
PR Newswire · Aug 31, 2026 12:45 PM
NeuroSense Issues CEO Letter to Shareholders
PR Newswire · Aug 13, 2026 1:30 PM
NeuroSense Completes PrimeC Pre-NDS Process and Advances Toward December 2026 Filing with Health Canada
PR Newswire · Aug 6, 2026 3:29 PM
NeuroSense Advances PrimeC Toward New Drug Submission to Health Canada for ALS
PR Newswire · Jul 22, 2026 12:30 PM
NeuroSense Says Phase 2b Trial of PrimeC in Amyotrophic Lateral Sclerosis Meets Primary Endpoint
MT Newswires · Jun 29, 2026 2:00 PM
NeuroSense Achieves Primary Endpoint in Phase 2b ALS Study with Statistically Significant Reduction of TDP-43, the Defining Pathological Hallmark of ALS
PR Newswire · Jun 29, 2026 1:30 PM
NeuroSense Reports Positive Biomarker Findings from Phase 2 RoAD Proof-of-Concept Study of PrimeC in Alzheimer's Disease
PR Newswire · Jun 25, 2026 1:20 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See NRSNW's money flow as a full page
Social Sentiment
No Reddit posts found for NRSNW.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.